39 minutes | May 21, 2020

Health Policy with Congresswoman Dingell (D-Mich.)

In this episode, we spoke with Congresswoman Debbie Dingell (D-Mich.) about her history in politics and her passion for advocating for health issues, as well as her thoughts on COVID-19 and how health care providers can effect change by engaging with their representatives.    Intro :10 About Congresswoman Dingell :14 The interview 2:38 Can you talk to us about your background? 2:40 What positions did you hold at GM? 3:35 Were you with GM during the auto crisis? 4:06 How did you get involved in politics? 4:55 Women’s health issues 6:22 Can you talk about Congressman Dingell’s health care advocacy work? 7:07 Do you think we’re entering an environment where people will be more likely to engage in meaningful public health conversations? 9:46 Can you talk about your brush with health care issues? 12:45 What are your feelings on us cooperating on an international basis to reach a solution on COVID-19 as quickly as possible? 16:07 How are you interacting on Capitol Hill? 18:42 What will happen with the election? 20:41 Do you think, at the national level, some regulations on state licensure for physicians will roll back to their old ways? 21:59 The aftereffects of COVID-19 25:20 What are some of the misconceptions that physicians or providers have about the role of a congressperson and their ability to affect change? 26:59 Health care costs 30:59 How can our listeners engage with their congressperson or senator? 33:25 If you were advising Vice President Biden, what advice would you give him leading up to the election? 37:01 What advice would you have for President Trump 37:50 Thank you so much for spending time with us, Congresswoman Dingell 38:02 Congresswoman Debbie Dingell (D-Mich.) represents the 12th District of Michigan in the U.S. House of Representatives. We’d love to hear from you! Send your comments/questions to guttalkpodcast@healio.com. Follow us on Twitter @HealioGastro @sameerkberry @umfoodoc Disclosures: Berry and Chey report no relevant financial disclosures.
Play Next